Work

Early antibody therapy can induce long-lasting immunity to SHIV

Year: 2017

Type: article

Source: Nature

DOI: 10.1038/nature21435

Authors: Yoshiaki Nishimura, Rajeev Gautam, Tae-Wook Chun, Reza Sadjadpour, Kathryn E. Foulds, Masashi Shingai, Florian Klein, Anna Gazumyan, Jovana Golijanin, Mitzi Donaldson, Olivia K. Donau, Ronald J. Plishka, Alicia Buckler-White, Michael S. Seaman, Jeffrey D. Lifson, Richard A. Koup, Anthony S. Fauci, Michel C. Nussenzweig, Malcolm A. Martin

Institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases, Vaccine Research Center, University of Cologne, Rockefeller University, Beth Israel Deaconess Medical Center, Frederick National Laboratory for Cancer Research, Howard Hughes Medical Institute

Language: English

Topic: HIV Research and Treatment

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Howard Hughes Medical Institute, Gilead Sciences, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases

Awards: G2224138519, G386607036, G5888954722, Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Resource fo Nonhuman Primate Cell Depleting Antibodies, Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies

OpenAlex ID: W2597074085

FWCI: 20.23

Cites: 36

Cited by: 313

Related to: 10